Diastolic blood pressure
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genome-wide association study of blood pressure and hypertension.
|
19430479 |
2009 |
Systolic Pressure
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genome-wide association study of blood pressure and hypertension.
|
19430479 |
2009 |
Diastolic blood pressure measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
Genome-wide association study of blood pressure and hypertension.
|
19430479 |
2009 |
Systolic blood pressure measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
Genome-wide association study of blood pressure and hypertension.
|
19430479 |
2009 |
Hypertensive disease
|
0.020 |
GeneticVariation
|
group |
BEFREE |
Four loci-ATP2B1 (ATPase, Ca(++) transporting, plasma membrane 1), CSK (c-src tyrosine kinase), CYP17A1 (cytochrome P450 17A1) and PLEKHA7 (pleckstrin homology domain-containing family A member 7)-were associated with blood pressure and hypertension in the Korean population.
|
20414254 |
2010 |
Coronary heart disease
|
0.100 |
GeneticVariation
|
disease |
GWASDB |
Genome-wide association study of coronary heart disease and its risk factors in 8,090 African Americans: the NHLBI CARe Project.
|
21347282 |
2011 |
Blood Pressure
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure.
|
21909110 |
2011 |
Mean blood pressure
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure.
|
21909110 |
2011 |
Systolic blood pressure measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk.
|
21909115 |
2011 |
Hypertensive disease
|
0.020 |
GeneticVariation
|
group |
BEFREE |
Two variants in CACNB2 and PLEKHA7 were found to be significantly related to hypertension (odds ratios [OR] and (95% confidence interval [CI]): 0.79 (0.65-0.97) and 1.19 (1.01-1.41), respectively) in logistic regression analyses after adjusted by age, sex and BMI.
|
21963141 |
2011 |
Carcinoma, Lobular
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Genetic up-regulation and overexpression of PLEKHA7 differentiates invasive lobular carcinomas from invasive ductal carcinomas.
|
22542108 |
2012 |
Ductal Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Genetic up-regulation and overexpression of PLEKHA7 differentiates invasive lobular carcinomas from invasive ductal carcinomas.
|
22542108 |
2012 |
Angle Closure Glaucoma
|
0.400 |
Biomarker
|
disease |
CTD_human |
Genome-wide association analyses identify three new susceptibility loci for primary angle closure glaucoma.
|
22922875 |
2012 |
Glaucoma
|
0.120 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide association analyses identify three new susceptibility loci for primary angle closure glaucoma.
|
22922875 |
2012 |
Glaucoma, Open-Angle
|
0.100 |
GeneticVariation
|
disease |
GWASDB |
Genome-wide association analyses identify three new susceptibility loci for primary angle closure glaucoma.
|
22922875 |
2012 |
Angle Closure Glaucoma
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Three loci defined by single nucleotide polymorphisms (SNPs) rs11024102 in PLEKHA7, rs3753841 in COL11A1, and rs1015213 between the PCMTD1 and ST18 genes, recently have been associated with primary angle closure glaucoma (PACG).
|
23847314 |
2013 |
Primary angle-closure glaucoma
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Three loci defined by single nucleotide polymorphisms (SNPs) rs11024102 in PLEKHA7, rs3753841 in COL11A1, and rs1015213 between the PCMTD1 and ST18 genes, recently have been associated with primary angle closure glaucoma (PACG).
|
23847314 |
2013 |
Glaucoma
|
0.120 |
Biomarker
|
disease |
BEFREE |
Further work with a larger sample size is necessary to confirm the importance of COL11A1 and PLEKHA7 in the pathogenesis of glaucoma.
|
23847314 |
2013 |
Angle Closure Glaucoma
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Three susceptibility loci for primary angle-closure glaucoma (PACG) were recently identified: PLEKHA7 rs11024102, COL11A1 rs3753841, and rs1015213 located in the intergenic region between PCMTD1 and ST18.
|
23920366 |
2013 |
Primary angle-closure glaucoma
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Three susceptibility loci for primary angle-closure glaucoma (PACG) were recently identified: PLEKHA7 rs11024102, COL11A1 rs3753841, and rs1015213 located in the intergenic region between PCMTD1 and ST18.
|
23920366 |
2013 |
Angle Closure Glaucoma
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Recently, three genetic susceptibility loci for primary angle closure glaucoma (PACG) were identified: COL11A1 rs3753841, PCMTD1-ST18 rs1015213, and PLEKHA7 rs11024102.
|
24474268 |
2014 |
Primary angle-closure glaucoma
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Recently, three genetic susceptibility loci for primary angle closure glaucoma (PACG) were identified: COL11A1 rs3753841, PCMTD1-ST18 rs1015213, and PLEKHA7 rs11024102.
|
24474268 |
2014 |
Angle Closure Glaucoma
|
0.400 |
Biomarker
|
disease |
BEFREE |
Specific localization of PLEKHA7 was found within PACG-related structures (iris, ciliary body, and choroid) and blood-aqueous barrier (BAB) structures (posterior iris epithelium, nonpigmented ciliary epithelium, iris and ciliary body microvasculature).
|
24801512 |
2014 |
Primary angle-closure glaucoma
|
0.200 |
Biomarker
|
disease |
BEFREE |
Specific localization of PLEKHA7 was found within PACG-related structures (iris, ciliary body, and choroid) and blood-aqueous barrier (BAB) structures (posterior iris epithelium, nonpigmented ciliary epithelium, iris and ciliary body microvasculature).
|
24801512 |
2014 |
Angle Closure Glaucoma
|
0.400 |
Biomarker
|
disease |
BEFREE |
Both COL11A1 and PLEKHA7 were shown to confer significant risk for acute PAC/PACG.
|
24854855 |
2014 |